General Catalyst Partners Company Profile

20:20 EDT 23rd March 2018 | BioPortfolio

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead innovation and transform industries. Founded in 2000, General Catalyst Partners leverages its principals' extensive operational, business development and technological expertise to provide portfolio companies with a catalyst for success through business-building and partnership development assistance. General Catalyst has offices in Cambridge, MA and Palo Alto, CA. For more information, visit:

News Articles [850 Associated News Articles listed on BioPortfolio]

Ken Chenault to Join General Catalyst

NEW YORK, Jan. 29, 2018/PRNewswire/ -- General Catalyst, a venture capital firm that makes early-stage and transformational investments, today announced that Ken Chenault Read more...

Catalyst Biosciences nets $9.8mm through public offering

Catalyst Biosciences Inc. netted $9.8mm through a public sale of 1.1mm common shares at $9.50. The company is developing protease-based therapies for hemophilia and plans to use the offering proceeds ...

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q3 2017 Results - Earnings Call Transcript

Catalyst Pharmaceutical Partners' (CPRX) CEO Patrick McEnany on Q4 2017 Results - Earnings Call Transcript

Highly efficient ammonia synthesis catalyst developed

Researchers have discovered that a catalyst of calcium amide with a small amount of added barium (Ba-Ca(NH2)2) with ruthenium nanoparticles immobilized onto it can synthesize ammonia at an efficiency ...

Umicore to Buy Materia’s Metathesis Catalyst Arm

Belgian materials technology and recycling group Umicore has agreed to acquire the metathesis catalyst business of Pasadena, California-based Materia Inc., valuing the assets at $27 million. Umicore s...

Catalyst eyes 2018 filing for rare disease drug candidate

Positive data from a second Phase 3 study has Catalyst on track to resubmit Firdapse for potential U.S. approval.

In The Spotlight: Catalyst Pharmaceuticals

Shares of Catalyst Pharmaceuticals Inc. (CPRX) are up an impressive 179% year-to-date while the iShares NASDAQ Biotechnology Index ETF (IBB) has gained just 17% during the same period.

Drugs and Medications [22 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]


Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [1354 Associated PubMed Articles listed on BioPortfolio]

Concurrent validity of the Partners in Health scale against general self-rated health in chronic conditions: A short report.

The Partners in Health scale is a structurally valid measure of chronic condition self-management behaviours. This report describes a study that further evaluated construct validity of Partners in Hea...

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

Silica-Supported Lanthanocene(II) - (SiO)LnCp* (Ln = Yb, Sm): Ultra High Molecular Weight Polyethylene without co-Catalyst.

Designing highly active supported ethylene polymerization catalysts that do not require a co-catalyst to generate electrophilic metal alkyl species is still a challenge despite its industrial relevanc...

Industrial wastewater advanced treatment via catalytic ozonation with an Fe-based catalyst.

An Fe-based catalyst was used as a heterogeneous catalyst for the ozonation of industrial wastewater, and key operational parameters (pH and catalyst dosage) were studied. The results indicated that t...

A solid iridium catalyst for diastereoselective hydrogenation.

An Ir(NHC) supported catalyst is used in the selective hydrogenation of terpinen-4-ol to cis p-menthan-4-ol. Its activity, selectivity and stability are compared to those of a homogeneous homologue [I...

Clinical Trials [1930 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

A Case Control Study of Women With Multiple Sexual Partners

Both population based surveys and more focused research studies indicate that increased numbers of sexual partners and partner concurrency contribute to increased risk for acquisition of s...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [1674 Associated Companies listed on BioPortfolio]

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

Catalyst Pharmaceutical Partners, Inc.

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromu...

SynapDx Corporation

SynapDx is a private company providing laboratory diagnostic services to physicians who suspect children of developmental disorders, with the initial goal of enabling earli...

Catalyst Communications

Catalyst [Kat-a-list] noun: 1. a powerful agent whose action inspires substantial change and the creation of new, different entities. 2. an agent that increases the rate of change in systems. ...

More Information about "General Catalyst Partners" on BioPortfolio

We have published hundreds of General Catalyst Partners news stories on BioPortfolio along with dozens of General Catalyst Partners Clinical Trials and PubMed Articles about General Catalyst Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of General Catalyst Partners Companies in our database. You can also find out about relevant General Catalyst Partners Drugs and Medications on this site too.

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record